Notice Regarding Completion of JT Group’s Pharmaceutical Business to Shionogi & Co., Ltd. through a Company Simplified Absorption-Type Split12/1TDnetPDF(19KB)
Consolidated Financial Results for the Nine Months Ended September 30,2025 <under IFRS>10/30TDnetPDF(471KB)
Notice Regarding the Conclusion of an Absorption-Type Split Contract Related to the Transfer of JT Group's Pharmaceutical Business9/25TDnetPDF(21KB)
Notice of the Completion of New Issuance and Tender Offer of Foreign Currency Denominated Subordinated Bond by JT’s Foreign Subsidiary9/5TDnetPDF(217KB)
Notice of New Issuance and Tender Offer of Foreign Currency Denominated Subordinated Bonds by JT’s Foreign Subsidiary8/27TDnetPDF(212KB)
Partial re-correction of “2024 Full Year Results & 2025 Forecasts (All Presentation)”8/21TDnetPDF(121KB)
Notice concerning increase of dividends of surplus and revise of dividend forecast7/31TDnetPDF(218KB)